Most Popular
Newsletter
Research Trend
How to Choose the Right Mouse Models and Genetic Modification Method for Your Research
Mar 30, 2020
Our experts put together the following advice on how to choose the most suitable mouse strains & genetic modification techniques for your research. In practical applications, it is necessary to select mouse strain backgrounds that align with your desired research applications to achieve good experimental results. Read More >
Newsletter
Breaking News
Expanded Knockout Catalog Models – Over 10k Genes Now Available
Mar 24, 2020
In our continuing efforts to expand the gene knockout models offered in the Cyagen Knockout Catalog, described in our recent Technical Bulletin, we are proud to announce the availability of over 10,000 KO mouse models. Read More >
Newsletter
ROSA26: The ‘Safe Harbor’ Locus in the Mouse Genome
Mar 23, 2020
What is the first thing that comes to your mind when we mention ‘safe harbor’? The ‘safe harbor’ we want to talk about today is not the kind for ships, but, rather, the safe locus for targeted integration of exogenous gene in the mouse genome. Let's explore one of the most well-established safe loci in the mouse genome - ROSA26. Read More >
Newsletter
COVID-19
Interview: Impact of COVID-19 Respiratory Illness on the Life Science Research Industry
Mar 20, 2020
With the gradual improvement of the COVID-19 situation in China in the past few days, along with a worsening situation across many regions, research on vaccines and related antiviral drugs has become a key issue for most people both inside and outside the life science research industry. Read More >
Newsletter
Research Trend
COVID-19
Cytokine Storm: The New Perspective for COVID-19 Research
Mar 19, 2020
Since COVID-19 poses a significant threat to public health and also represents a challenge for antiviral drug development and administration globally, current efforts focus on prevention and control while accelerating the research on the SARS-CoV-2 coronavirus, which has caused the outbreak of COVID-19. Read More >
Newsletter
CRISPR-Pro Versus ES Cell Targeting：Which is the Optimal Solution?
Mar 19, 2020
With the rapid advancement of biomedical technology in recent years, customized treatment methods such as targeted medicine, immunotherapy, and gene therapy have become the main directions of biomedical innovation - which is intimately related to the development of gene-editing technology. Read More >
Newsletter
BALB/c Strains Now Available for TurboKnockout® Embryonic Stem Cell (ESC) Mediated Services
Mar 18, 2020
Cyagen is proud to announce the availability of BALB/c mouse models for all embryonic stem cell (ESC) based gene targeting services, including our proprietary TurboKnockout® technology. Read More >
Newsletter
Research Trend
White Paper
COVID-19
Researching the New Coronavirus, SARS-CoV-2: Applications for Animal Models
Mar 10, 2020
The novel coronavirus, now officially designated as SARS-CoV-2, was first identified in Wuhan, Hubei Province, China in December of 2019. This virus has led to an outbreak of COVID-19 (Coronavirus Disease in 2019), which is associated with acute respiratory illness and infection, as is common for diseases caused by the coronavirus family. Read More >
Newsletter
Breaking News
Cyagen Knockout Catalog Models Now Available in the US & Europe
Mar 04, 2020
As the leader in custom genetically engineered mouse and rat models, Cyagen has generated thousands of custom knockout (KO), knockin (KI), and transgenic rodent lines for its customer base that covers over 2,000 universities and companies worldwide. This rapid growth has seen the number of publications citing Cyagen in high-impact journals such as Nature, Cell and Science increase to over 3,400 in record time. Read More >
Newsletter
Research Trend
A Guide to Stem Cell Research: Disease Models and Clinical Applications in 2020
Jan 21, 2020
This guide offers a quick introduction to stem cells, current stem cell research efforts, widely-used stem cell treatments, and clinical trials currently underway in 2020. Read More >